Document:

exv10w1

 

EXHIBIT 10.1

AMENDED & RESTATED

EMPLOYMENT AGREEMENT

     THIS AMENDED AND RESTATED EMPLOYMENT AGREEMENT (the “Agreement”), amends and restates that
certain Amended and Restated Employment Agreement by and between Thermo Fisher Scientific Inc.
(formerly Thermo Electron Corporation), a Delaware corporation (together with its successors and
assigns permitted under this Agreement, the “Company”), and Marijn Dekkers (the “Executive”), dated
as of November 21, 2002, including any amendments or restatements thereto (the “Prior Agreement”).
The effective date of this Amended and Restated Employment Agreement
is April 7, 2008 (the
“Effective Date”).

WITNESSETH

     WHEREAS, the Company and the Executive desire to amend and restate the Prior Agreement in
accordance with the terms set forth in this Agreement;

     NOW, THEREFORE, in consideration of the promises and mutual covenants contained herein and for
other good and valuable consideration, the receipt of which is mutually acknowledged, the Company
and the Executive (individually a “Party” and together the “Parties”) agree as follows:

     1. Definitions.

          (a) “Accrued Obligations” shall have the meaning set forth in Section 10(a)(i) of this
Agreement.

          (b) “Affiliate” of a person or other entity shall mean a person or other entity that directly
or indirectly controls, is controlled by, or is under common control with the person or other
entity specified.

          (c) “Base Salary” shall mean the salary provided for in Section 4 below or any increased
salary granted to the Executive pursuant to Section 4.

          (d) “Board” shall mean the Board of Directors of the Company.

          (e) “Cause” shall mean:

          (i) the Executive commits a felony or any crime involving moral turpitude, or any
conduct by the Executive that would reasonably be expected to result in a material injury to
the Company if he were retained in his position, in each case as determined by the Board;

          (ii) in carrying out his duties, the Executive intentionally engages in conduct that
constitutes gross neglect or gross misconduct or any material violation of this Agreement or
any material violation of applicable Company rule or policy, the violation of which amounts
to gross neglect or gross misconduct, which, in each case that is curable, is not cured by
the Executive within 30 days following written notice of such conduct from the Board; or

 

          (iii) the Executive’s willful failure to respond to reasonable requests made by the
full Board (or by a committee of the Board that has been established by the full Board) in
connection with (1) a bona fide internal investigation relating to the Company that has been
approved by the full Board (or by a committee of the Board that has been established by the
full Board) or (2) a bona fide investigation relating to the Company by a federal or state
regulatory or law enforcement authority, or the Executive’s willful destruction of documents
or other materials known by Executive to be relevant to such investigation, or the
Executive’s willful destruction of documents or other materials not in accordance with
Company policies (including any Company retention policy), or the Executive’s willful
inducement of others to fail to cooperate or to produce documents or other materials, in
each case which has continued for more than 30 days following written notice of such failure
from the Board. Any determination to terminate Executive’s employment for Cause as provided
above shall be made by the full Board following any applicable cure period as provided above
and following an opportunity for Executive to be heard by the full Board.

          (f) “Code” shall mean the Internal Revenue Code of 1986, as amended.

          (g) “Disability” shall mean the Executive’s inability, due to physical or mental incapacity,
to substantially perform his duties and responsibilities as provided in this Agreement for 180 days
(including weekends and holidays ) in any 365-day period. The existence of any such physical or
mental incapacity shall be determined by a medical doctor selected by the Company and the
Executive. If the Parties cannot agree on a medical doctor, each Party shall select a medical
doctor and the two doctors shall select a third who shall be the approved medical doctor for this
purpose.

          (h) “Effective Date” shall have the meaning set forth in the preamble to this Agreement.

          (i) “Executive Retention Agreement” shall mean that certain Executive Retention Agreement by
and between the Executive and the Company dated as of November 21, 2002.

          (j) “Exercise Period” shall mean the maximum period in which stock options granted to the
Executive are exercisable pursuant to the applicable award agreement under which such stock options
were granted (i.e., the period ending on such stock option’s stated expiration date).

          (k) “Good Reason” shall mean termination by the Executive of his employment, after written
notice to the Company within 30 days following the occurrence of any of the following events
without his consent:

          (i) a reduction in the Executive’s then current Base Salary or Reference Bonus Amount
opportunity;

          (ii) the removal by the Board of Executive from any position described in Section 3 of
this Agreement;

2

 

          (iii) a material diminution in the Executive’s duties or responsibilities, including
the assumption by the Board (in its entirety or by an member(s)) of any duty or
responsibility that was previously the duty or responsibility of the Executive or his
reports (other than bona fide temporary assumptions connected with the departure of one or
more of his reports, provided that the Company in good faith is conducting a search for a
replacement);

          (iv) a change in the reporting structure so that (A) the Executive reports to any
single person, or so that the Executive reports to any person(s) or entity other than the
full Board, or (B) any officer or other member of senior management of the Company
(including the Chief Operating Officer, Chief Financial Officer and General Counsel) reports
to any person or entity other than the Executive (either directly or with the Executive’s
consent to another officer or member of senior management of the Company who reports to the
Executive);

          (v) the failure of the Company to obtain the assumption in writing of its obligation to
perform this Agreement by any successor to all or substantially all of the assets of the
Company within 15 days after a merger, consolidation, sale or similar transaction; or

          (vi) a material breach of this Agreement by the Company.

     Notwithstanding anything to the contrary, any action or event taken by the Board in good faith
after receiving advice of counsel to comply with any applicable law, regulation, rule, order or
other legal requirement, shall not constitute Good Reason. Following written notice from the
Executive, as described above, the Company shall have 30 days in which to cure. If the Company
fails to cure, the Executive’s termination shall become effective on the 31st day following the
written notice.

          (l) “Pro-Rata Bonus” shall mean a pro-rata annual cash incentive award for the year in which
the Termination Date occurs (for the period through the Termination Date), based on the amount of
the annual cash incentive award that would otherwise have been paid to the Executive based on his
Reference Bonus Amount under the Company’s annual cash incentive award plan for such year, after
giving effect to any determination (including so-called “negative discretion”) by the Board or the
Compensation Committee of the Board under such annual cash incentive award plan (such
determinations in a manner consistent with how such determinations are applied with respect to the
other named executive officers of the Company for such year), payable when annual cash incentive
awards are normally paid to other executives.

          (m) “Severance Bonus” shall have the meaning set forth in Section 10(a)(i) of this Agreement.

          (n) “Stock” shall mean the common stock of the Company.

          (o) “Termination Date” shall mean in the case of either a voluntary or involuntary
termination, the last day upon which Executive works. In the event of the Executive’s death, the
Termination Date is the date of death. In the case of a Disability, the Termination Date is the
date upon which the Executive receives written notice from the Board

3

 

that it has deemed him to have a Disability, but in no event before the Executive is
determined to have a Disability (as the term is defined in Section 1(h)).

     2. Term of Employment, Effect on Prior Agreements.

          (a) The Term of Employment (“Term” or “Term of Employment”) under this Agreement shall extend
until December 31, 2017. Notwithstanding the foregoing, the “Term of Employment” hereunder may be
earlier terminated by either Party in accordance with the provisions of Section 10.

          (b) Effect on Prior Agreements, Equity Awards. It is specifically acknowledged,
understood and agreed by the Parties that this Agreement amends and restates the Prior Agreement,
as of the Effective Date; provided, however, that nothing contained herein shall amend or restate
the terms of any restricted stock or stock option granted to the Executive prior to March 1, 2008
in a manner that would be adverse to the Executive, including any provision herein relating to
vesting or term of exercise.

     3. Position, Duties and Responsibilities.

          (a) During the Term of Employment, the Executive shall be employed as the President and Chief
Executive Officer of the Company. Executive shall devote his full working time and efforts to the
business and affairs of the Company.

          (b) The Executive shall be responsible for such duties and responsibilities that are assigned
to him from time to time by the full Board.

          (c) The Executive, in carrying out his duties under this Agreement, shall report directly to
the full Board, and each officer or other member of senior management of the Company (including the
Chief Operating Officer, Chief Financial Officer and General Counsel) shall report to the Executive
(either directly or with the Executive’s consent to another officer or member of senior management
of the Company who reports to the Executive);.

          (d) In the event of a termination of employment of the Executive for any reason, the Executive
shall immediately resign as a member of the Board of the Company and each of its Affiliates, unless
requested by the Board to remain in any such position.

          (e) Nothing herein shall preclude the Executive from (i) serving on the boards of directors of
a reasonable number of other corporations subject to the approval of the Board in each case, (ii)
serving on the boards of a reasonable number of trade associations and/or charitable organizations,
(iii) engaging in charitable activities and community affairs, and (iv) managing his personal
investments and affairs, provided that such activities set forth in this Section 3(e) do not
materially interfere with the proper performance of his duties and responsibilities hereunder.

     4. Base Salary. The Executive shall be paid an annualized Base Salary, payable in
accordance with the regular payroll practices of the Company, of $1,165,000 (effective as of April
1, 2008), which amount shall be subject to review annually and may be increased (but not decreased)
in the discretion of the Board.

4

 

     5. Annual Cash Incentive Award. During the Term of Employment, the Executive shall
participate in the annual cash incentive award program of the Company. Under such program, the
Executive shall have a reference bonus each calendar year equal to 125% of the Executive’s then
current Base Salary (the “Reference Bonus Amount”), prorated for partial years. The actual bonus
paid will be a multiple of the Reference Bonus Amount (from zero (0) to two (2) times the Reference
Bonus Amount). The actual multiple will reflect a variety of subjective and objective factors, as
determined by the Board. The Executive shall be paid his annual cash incentive award at the same
time that other senior executives are paid their annual cash incentive awards.

     6. Equity Incentive Awards. During the Term, the Executive shall be eligible to
receive equity incentive awards, including options to purchase shares of Stock, as determined by
the Compensation Committee of the Board. Any such equity incentive awards shall be granted in
accordance with the terms and conditions of the applicable equity incentive plan then in effect.
Each grant will be evidenced by an award agreement issued under the plan, which shall be executed
by the Executive and the Company and the terms of which shall be consistent with the terms of this
Agreement. Notwithstanding anything to the contrary, the second sentence of Section 10.7 of the
Company’s 2001 Equity Incentive Plan shall not apply to any equity incentive awards previously or
hereafter granted to the Executive. Further notwithstanding anything to the contrary, any
termination of the Executive’s employment that is not a termination by the Company for Cause under
this Agreement, shall under no circumstance be treated as a termination for “cause” under any
equity incentive awards previously or hereafter granted to the Executive.

     7. Employee Benefit Programs. During the Term, the Executive shall be entitled to
participate in all employee pension and welfare benefit plans and programs made available to the
Company’s senior level executives or to its employees generally, as such plans or programs may be
in effect from time to time, including, without limitation, pension, profit sharing, savings and
other retirement plans or programs, medical, dental, hospitalization, short-term and long-term
disability and life insurance plans, accidental death and dismemberment protection, travel accident
insurance, and any other pension or retirement plans or programs and any other employee welfare
benefit plans or programs that may be sponsored by the Company from time to time, including any
plans that supplement the above-listed types of plans or programs, whether funded or unfunded. In
no way limiting the foregoing, during the Term the Company will maintain, at its cost, term life
insurance on the life of the Executive for the benefit of his beneficiaries with a face amount
equal to at least $3,000,000. The Executive shall be entitled to four weeks paid vacation per year
of employment.

     8. Perquisites. During the Term, the Executive shall be entitled to participate in
all of the Company’s executive perquisites in accordance with the terms and conditions of such
arrangements as are in effect from time to time for the Company’s senior-level executives,
including without limitation, the Company’s automobile reimbursement arrangement.

     9. Reimbursement of Business and Other Expenses. The Executive is authorized to incur
reasonable expenses in carrying out his duties and responsibilities under this Agreement including,
without limitation, reasonable legal fees incurred in the negotiation and preparation of

5

 

this Agreement, and the Company shall promptly reimburse him for such expenses, subject to
documentation in accordance with the Company’s policy.

     10. Termination of Employment During the Term.

          (a) Termination Due to Death. In the event that the Executive’s employment is
terminated due to his death, his estate or his beneficiaries, as the case may be, shall be entitled
to the following benefits:

          (i) the sum of (1) the Executive’s Base Salary through the end of the month during
which the Termination Date occurs (to the extent not previously paid) (2) a pro-rata annual
cash incentive award for the year in which the Termination Date occurs, based on the
Reference Bonus Amount for such year, payable when annual cash incentive awards are normally
paid to other executives (to the extent not previously paid) (the “Severance Bonus”), (3)
any earned but unpaid annual cash incentive award for the year prior to the year in which
the Termination Date occurs, payable when annual cash incentive awards are normally paid to
other executives (the sum of the amounts described in clauses (1), (2) and (3), together
with expense reimbursements or other amounts payable to the Executive under any benefit
plan or policy of the Company or otherwise, shall be hereinafter referred to as the “Accrued
Obligations”);

          (ii) all outstanding stock options shall become fully vested and all stock options
granted prior to November 21, 2002 shall remain exercisable until two (2) years from the
Termination Date (but in no event beyond the end of each such stock option’s Exercise
Period) and all stock options granted on or after November 21, 2002 shall remain exercisable
until three (3) years from the Termination Date (but in no event beyond the end of each such
stock option’s Exercise Period); and

          (iii) the transfer restrictions on all outstanding restricted stock, restricted stock
units and other equity awards granted to the Executive that are subject to time-based
vesting at the time of termination shall lapse.

     All payments owing to the Executive’s estate or beneficiaries, as the case may be, shall be
made in a lump sum payment within 30 days of the date of Executive’s death.

          (b) Termination Due to Disability. In the event that the Executive’s employment is
terminated by either party due to his Disability, he shall be entitled to the following benefits:

          (i) disability benefits in accordance with the long-term disability (“LTD”) program
then in effect for senior executives of the Company;

          (ii) Base Salary through the end of the LTD elimination period;

          (iii) the Accrued Obligations;

          (iv) all outstanding stock options shall become fully vested and all stock options
granted prior to November 21, 2002 shall remain exercisable until two (2)

6

 

years from the Termination Date (but in no event beyond the end of each such stock
option’s Exercise Period ) and all stock options granted on or after November 21, 2002 shall
remain exercisable until three (3) years from the Termination Date (but in no event beyond
the end of each such stock option’s Exercise Period);

          (v) the transfer restrictions on all outstanding restricted stock, restricted stock
units and other equity awards granted to the Executive that are subject to time-based
vesting at the time of termination shall lapse; and

          (vi) the Executive shall be entitled to continued participation at Company expense in
all medical and dental insurance coverage in which he was participating on the Termination
Date until the longer of (x) the remaining Term of the Agreement following the Termination
Date, (y) 24 months following the Termination Date and (z) the date, or dates, he receives
equivalent coverage and benefits under the plans and programs of a subsequent employer.

     In no event shall a termination of Executive’s employment for Disability occur until the Party
terminating his employment gives written notice to the other Party in accordance with Section 24
below, and until Executive is determined to have a Disability as such term is defined in Section
1(g). All payments owing to the Executive under this subsection shall be made to the Executive in
a lump sum payment within 30 days of the Termination Date; provided, however, that if the Executive
is a “specified employee” within the meaning of Section 409A of the Code and the guidance issued
thereunder on the Termination Date, then such payments shall be delayed until the date that is six
months and one day following the Termination Date, if and to the extent required to comply with
Section 409A of the Code.

          (c) Termination by the Company for Cause. In the event the Company terminates the
Executive’s employment for Cause, he shall be entitled to the following benefits:

          (i) the Accrued Obligations, excluding the Severance Bonus and excluding Base Salary
between the Termination Date and the end of the month during which the Termination Date
occurs;

          (ii) no further vesting of stock options shall occur and all vested options shall
remain exercisable until the expiration of the “Limited Term.” For purposes hereof, the
Limited Term shall be, (1) in the case of options granted after 2004, 10 days following the
Termination Date, and (2) in the case of options granted before 2005, 90 days following the
Termination Date, but not in either case beyond the end of each such stock option’s Exercise
Period. Notwithstanding the foregoing, if at any time during the Limited Term the Executive
is prohibited from exercising options or selling shares of Company stock by reason of (A) a
Company policy, including the Company’s insider trading policy, or (B) any legal or
regulatory restriction or limitation (in each case, a “Period of Restriction”), then the
Limited Term shall end on the later of the date described in the preceding sentence or the
date which is 10 days following the end of the Period of Restriction, but not in either case
beyond the end of each such stock option’s Exercise Period; and

7

 

          (iii) all restricted stock, restricted stock units and other equity awards granted to
the Executive, under this Agreement or any other agreement, as to which transfer
restrictions have not lapsed shall be forfeited.

     All payments owing to the Executive under this subsection shall be made to the Executive in a
lump sum payment within 30 days of the Termination Date; provided, however, that if the Executive
is a “specified employee” within the meaning of Section 409A of the Code and the guidance issued
thereunder on the Termination Date, then such payments shall be delayed until the date that is six
months and one day following the Termination Date, if and to the extent required to comply with
Section 409A of the Code.

          (d) Termination without Cause or for Good Reason. In the event the Executive’s
employment is terminated by the Company without Cause or by the Executive with Good Reason (but not
in any event as a result of Disability, death, or as the result of a termination with Cause or
without Good Reason), the Company shall pay to the Executive the Pro-Rata Bonus and the Accrued
Obligations, excluding the Severance Bonus. In addition, the Executive shall be entitled to the
following:

          (i) the Company shall pay to the Executive the aggregate of following amounts in a lump
sum payment within 30 days of the Termination Date; provided, however, that if the Executive
is a “specified employee” within the meaning of Section 409A of the Code and the guidance
issued thereunder on the Termination Date, then such payments shall be delayed until the
date that is six months and one day following the Termination Date, if and to the extent
required to comply with Section 409A of the Code:

          (A) the sum of the Base Salary for the 36-month period following the
Termination Date; and

          (B) three (3) times the Reference Bonus Amount;

          (ii) for two (2) years after the Termination Date, the Company shall continue to
provide medical and dental benefits to the Executive and the Executive’s family at least
equal to those which would have been provided to them if the Executive’s employment had not
been terminated, in accordance with the applicable medical and dental benefit plans in
effect on the Termination Date and in which Executive participated as of such date or, if
more favorable to the Executive and his family, in effect generally at any time thereafter
with respect to other peer executives of the Company and its affiliated companies; provided,
however, that if the Executive becomes reemployed with another employer and is eligible to
receive medical and dental benefits from such employer on terms at least as favorable to the
Executive and his family as those being provided by the Company, then the Company shall no
longer be required to provide those particular benefits to the Executive and his family. In
addition, in the event the Executive receives such benefits pursuant to the preceding
sentence for the entire two-year period and as of the end of such two-year period the
Executive is not eligible to receive medical and dental benefits from a subsequent employer,
then at the end of such two-year period the Company shall make a lump sum payment to the
Executive in an amount equal to the Company’s cost of providing such medical and dental
benefits pursuant to the preceding

8

 

sentence for a one-year period, with such amount based on the relevant rates in effect
as of the last day of such two-year period;

          (iii) all outstanding stock options shall become fully vested and all stock options
granted prior to November 21, 2002 shall remain exercisable until two (2) years from the
Termination Date (but in no event beyond the end of each such stock option’s Exercise Period
) and all stock options granted on or after November 21, 2002 shall remain exercisable until
three (3) years from the Termination Date (but in no event beyond the end of each such stock
option’s Exercise Period);

          (iv) the transfer restrictions on all outstanding restricted stock, restricted stock
units and other equity awards granted to the Executive that are subject to time-based
vesting at the time of termination shall lapse; and

          (v) notwithstanding anything to the contrary in this Agreement or in the Executive
Retention Agreement, if the Executive’s employment with the Company is terminated under
circumstances which entitle the Executive to receive benefits under the terms of the
Executive Retention Agreement and this Agreement, the Executive shall be entitled to
benefits equal to the greater of (1) the benefits due and payable to him under Section 4 of
the Executive Retention Agreement as a result of such termination or (2) the benefits due
and payable to him under this Section 10 as a result of such termination, but not both. In
furtherance thereof, it is the Parties’ understanding that in the event of a termination
under such circumstances, the Executive shall be entitled to receive benefits payable under
Section 10 of this Agreement or Section 4 of the Executive Retention Agreement (but not
both) determined on a benefit by benefit basis by the Executive and that the term “Other
Benefits” as defined in the Executive Retention Agreement shall not include benefits payable
under this Agreement.

          (e) Voluntary Termination. A termination of employment by the Executive on his own
initiative, other than a termination due to death or Disability or Good Reason, shall have the same
consequences as provided in Section 10(c) for a termination for Cause. A voluntary termination
under this Section 10(e) shall be effective upon 30 days prior written notice to the Company.

     All payments owing to the Executive under this subsection shall be made to the Executive in a
lump sum payment within 30 days of the Termination Date; provided, however, that if the Executive
is a “specified employee” within the meaning of Section 409A of the Code and the guidance issued
thereunder on the Termination Date, then such payments shall be delayed until the date that is six
months and one day following the Termination Date, if and to the extent required to comply with
Section 409A of the Code.

          (f) Taxes.

          (i) In the event that the Company undergoes a “Change in Ownership or Control” (as
defined below), including any Change in Ownership or Control prior to the Effective Date,
and thereafter the Executive becomes eligible to receive “Contingent Compensation Payments”
(as defined below) the Company shall, as soon as

9

 

administratively feasible after the Executive becomes so eligible determine and notify
the Executive (with reasonable detail regarding the basis for its determinations) (A) which
of the payments or benefits due to the Executive following such Change in Ownership or
Control constitute Contingent Compensation Payments, (B) the amount, if any, of the excise
tax (the “Excise Tax”) payable pursuant to Section 4999 of the Code, by the Executive with
respect to such Contingent Compensation Payment and (C) the amount of the “Gross-Up Payment”
(as defined below) due to the Executive with respect to such Contingent Compensation
Payment. Within 30 days after delivery of such notice to the Executive, the Executive shall
deliver a response to the Company (the “Executive Response”) stating either (1) that he
agrees with the Company’s determination pursuant to the preceding sentence or (2) that he
disagrees with such determination, in which case he shall indicate which payment and/or
benefits should be characterized as a Contingent Compensation Payment, the amount of the
Excise Tax with respect to such Contingent Compensation Payment and the amount of the
Gross-Up Payment due to the Executive with respect to such Contingent Compensation Payment.
If the Executive states in the Executive Response that he agrees with the Company’s
determination, the Company shall make the Gross-Up Payment to the Executive within three (3)
business days following delivery to the Company of the Executive Response. If the Executive
states in the Executive Response that he disagrees with the Company’s determination, then,
for a period of 15 days following delivery of the Executive Response, the Executive and the
Company shall use good faith efforts to resolve such dispute. If such dispute is not
resolved within such 15-day period, such dispute shall be settled by arbitration in
accordance with Section 14 below. The Company shall, within three (3) business days
following delivery to the Company of the Executive Response, make to the Executive those
Gross-Up Payments as to which there is no dispute between the Company and the Executive
regarding whether they should be made. The balance of the Gross-Up Payments shall be made
within three (3) business days following the resolution of such dispute. The amount of any
payments to be made to the Executive following the resolution of such dispute shall be
increased by the amount of the accrued interest thereon computed at the prime rate announced
from time to time by The Wall Street Journal compounded monthly from the date that such
payments originally were due. In the event that the Executive fails to deliver an Executive
Response on or before the required date, the Company’s initial determination shall be final.

          (ii) For purposes of this Section 10(f), the following terms shall have the following
respective meanings:

          (A) “Change in Ownership or Control” shall mean a change in the ownership or
effective control of the Company or in the ownership of a substantial portion of the
assets of the Company determined in accordance with Section 280G(b)(2) of the Code.

          (B) “Contingent Compensation Payment” shall mean any payment (or benefit) in
the nature of compensation that is made or supplied to a “disqualified individual”
(as defined in Section 280G(c) of the Code) and that is contingent (within the
meaning of Section 280G(b)(2)(A)(i) of the Code) on a Change in Ownership or Control
of the Company.

10

 

          (C) “Gross-Up Payment” shall mean an amount equal to the sum of (i) the amount
of the Excise Tax payable with respect to a Contingent Compensation Payment and (ii)
the amount necessary to pay all additional taxes imposed on (or economically borne
by) the Executive (including the Excise Taxes, state and federal income taxes and
all applicable withholding taxes) attributable to the receipt of such Gross-Up
Payment. For purposes of the preceding sentence, all taxes attributable to the
receipt of the Gross-Up Payment shall be computed assuming the application of the
maximum tax rates provided by law.

          (g) Outplacement Services. In the event the Executive’s employment terminates in
accordance with Section 10(d), the Company shall provide outplacement services, including, but not
limited to the services of one or more executive search firms, a personal assistant and such other
services that the Executive believes will assist him in his job search, and pay reasonable
out-of-pocket expenses, each subject to the Executive’s presentation of appropriate vouchers,
invoices or receipts in accordance with such policies and procedures as the Company from time to
time may establish, up to an aggregate of $50,000, with such services and expense reimbursement to
extend until the earlier of (i) 12 months following the termination of the Executive’s employment
or (ii) the date the Executive secures full time employment.

          (h) Other Benefits. To the extent not previously paid or provided, the Company shall
timely pay or provide to the Executive any other amounts or benefits, including, but not limited to
any deferred compensation amounts, required to be paid or provided or which the Executive is
eligible to receive following the Executive’s termination of employment for any reason, under any
plan, program, policy, practice, contract or agreement of the Company and its Affiliates and in
accordance with such plan, program, policy, practice, contract or agreement, except that the
Executive waives any rights to severance pay thereunder.

          (i) Nature of Payments. Any amounts due under this Section 10 are in the nature of
severance payments considered to be reasonable by the Company and are not in the nature of a
penalty.

          (j) No Mitigation; No Offset. The Executive shall not be required to mitigate the
amount of any payment or benefit provided in this Section 10 or Section 11 by seeking other
employment or otherwise. Further, except as provided in Sections 10(b)(vi), 10(d)(ii) and Section
11(a), the amount of any payment or benefits provided for in this Section 10 or Section 11 shall
not be reduced by any compensation earned by the Executive as a result of employment by another
employer or be offset by any amount claimed to be owed by the Executive to the Company.

     11. Retirement Upon Expiration of the Term. In the event that the Executive’s
employment is terminated by the Company without Cause or the Executive (with or without Good
Reason) on or after December 31, 2017, the Company shall pay to the Executive the Pro-Rata Bonus
and the Accrued Obligations, excluding the Severance Bonus. In addition, the Executive shall be
entitled to the following:

11

 

          (a) for the period beginning on the Termination Date and ending on the date the Executive
becomes eligible for Medicare, or such longer period as may be provided by the term of the
appropriate plan, program, practice or policy, the Executive and the Executive’s family shall be
permitted to continue to participate, at Executive’s expense based on the applicable COBRA premium
rate, in the Company’s medical and dental benefit plans in effect generally with respect to other
peer executives of the Company and its affiliated companies; provided, however, that if the
Executive becomes reemployed with another employer and is eligible to receive medical and dental
benefits from such employer on terms at least as favorable to the Executive and his family as those
being provided by the Company, then the Company shall no longer be required to provide those
particular benefits to the Executive and his family;

          (b) except as otherwise provided in an applicable stock option agreement, all outstanding
stock options shall become fully vested, and all outstanding stock options shall remain exercisable
until the end of each such stock option’s Exercise Period; and

          (c) except as otherwise provided in an applicable award agreement, the transfer restrictions
on all outstanding restricted stock, restricted stock units and other equity awards granted to the
Executive that are subject to time-based vesting at the time of termination shall lapse.

     12. Confidentiality & Assignment of Inventions.

          (a) The Executive shall abide by his previously executed confidentiality and assignment of
inventions agreement, set forth in Exhibit A, attached and incorporated herein.

          (b) Upon the termination of the Executive’s employment, the Executive (or in the event of his
death, the Executive’s personal representative) shall promptly surrender to the Company the
original and all copies of any materials containing confidential information of the Company which
are then in the Executive’s possession or control, provided, however, the Executive shall not be
required to surrender his rolodexes, personal diaries and other items of a personal nature.

     13. Noncompetition; Nonsolicitation.

          (a) The Executive acknowledges (i) that in the course of his employment with the Company he
will become familiar with trade secrets and customer lists of, and other confidential information
concerning, the Company and its Affiliates, customers, and clients and (ii) that his services will
be of special, unique and extraordinary value to the Company.

          (b) The Executive agrees that during the Term of Employment and for a period of two (2) years
following his Termination Date (the “Noncompetition Period”), he shall not in any manner, directly
or indirectly, through any person, firm, corporation or enterprise, alone or as a member of a
partnership or as an officer, director, stockholder, investor or employee of or advisor or
consultant to any person, firm, corporation or enterprise or otherwise, engage or be engaged, or
assist any other person, firm, corporation or enterprise in engaging or being engaged
(collectively, (“Restricted Activity”)), in any Competitive Activity.

12

 

          (c) In the event the Executive’s employment is terminated pursuant to Section 10(d) or Section
11, a Competitive Activity shall mean a business that sells or offers for sale the product line or
product lines (i) of the Company or any Affiliate at the time in question and (ii) that were being
actively considered to be included in the Company’s or any Affiliate’s product line or product
lines, prior to the Termination Date of the Executive’s employment; provided that a Competitive
Activity shall not include a product line or product lines of the Company contributing less than
20% of the Company’s revenues for the year in question, and provided further that a product line or
product lines shall not be deemed to be a Competitive Activity if the product line or product lines
contribute less than 20% of the revenues for the year in question of the business by which the
Executive is employed or with which he is otherwise associated, and provided further that it is
agreed and understood that the prohibitions provided for in this Section 13(c) shall not restrict
Executive from engaging in Restricted Activity for any subsidiary, division or affiliate or unit of
a company (collectively a “Related Entity”) if that Related Entity is not engaged in Competitive
Activity, irrespective of whether some other Related Entity of that company engages in what would
otherwise be considered to be Competitive Activity (as long as Executive does not engage in
Restricted Activity for such other Related Entity).

          (d) In the event the Executive is terminated pursuant to Sections 10(c) or 10(e), a
Competitive Activity shall mean a business that sells or offers for sale the product line or
product lines (i) of the Company or any Affiliate at the time in question and (ii) that were being
actively considered to be included in the Company’s or any Affiliate’s product line or product
lines, prior to the Termination Date of the Executive’s employment; provided that a Competitive
Activity shall not include a product line or product lines of the Company contributing less than
five percent (5%) of the Company’s revenues for the year in question, and provided further that a
product line or product lines shall not be deemed to be a Competitive Activity if the product line
or product lines contribute less than five percent (5%) of the revenues for the year in question of
the business by which the Executive is employed or with which he is otherwise associated, and
provided further that it is agreed and understood that the prohibitions provided for in this
Section 13(d) shall not restrict Executive from engaging in Restricted Activity for any Related
Entity if that Related Entity is not engaged in Competitive Activity, irrespective of whether some
other Related Entity of that company engages in what would otherwise be considered to be
Competitive Activity (as long as Executive does not engage in Restricted Activity for such other
Related Entity).

          (e) The Executive further agrees that during the Noncompetition Period he shall not (i) in any
manner, directly or indirectly, hire or cause to be hired any employee of or advisor or consultant
to the Company or any of its Affiliates for any purpose or in any capacity whatsoever, or (ii) in
connection with any business to which Section 13(b) applies, call on, service, solicit or otherwise
do business with any customer of the Company or any of its Affiliates; provided, however, that the
restriction contained in clause (i) of this Section 13(e) shall not apply to, or interfere with,
the proper performance by the Executive of his duties and responsibilities under Section 3 of this
Agreement.

          (f) Nothing in this Section 13 shall prohibit the Executive from being a passive owner of not
more than one percent (1%) of the outstanding common stock, capital stock and equity of any firm,
corporation or enterprise so long as the Executive has no active participation in the management of
business of such firm, corporation or enterprise.

13

 

          (g) If the restrictions stated herein are found by a court to be unreasonable, the parties
hereto agree that the maximum period, scope or geographical area reasonable under such
circumstances shall be substituted for the stated period, scope or area and that the court shall
revise the restrictions contained herein to cover the maximum period, scope and area permitted by
law.

     14. Resolution of Disputes. Any disputes arising under or in connection with this
Agreement shall be resolved by binding arbitration, to be held in Boston, Massachusetts, in
accordance with the rules and procedures of the American Arbitration Association. Judgment upon
the award rendered by the arbitrator(s) may be entered in any court having jurisdiction thereof.
Costs of the mediation, arbitration or litigation including, without limitation, reasonable
attorneys’ fees of both parties, shall be borne by the Company. Pending the resolution of the
dispute, the Company shall continue payment of all amounts due and provisions of all benefits to
which Executive is entitled, which amounts shall be subject to repayment to the Company if the
Company prevails.

     15. Remedies. Each of the parties to this Agreement shall be entitled to enforce its
rights under this Agreement specifically, to recover damages and costs (including reasonable
attorney’s fees) caused by any breach of any provision of this Agreement and to exercise all other
rights existing in its favor. The parties hereto agree and acknowledge that money damages would
not be an adequate remedy for any breach of the provisions of this Agreement and that any party may
in its sole discretion apply to any court of law or equity of competent jurisdiction (without
posting any bond or deposit) for specific performance and/or other injunctive relief in order to
enforce or prevent any violations of the provisions of this Agreement. Nothing in this paragraph
is intended to prevent the parties from raising any and all defenses with respect to the necessity
for, and scope of, such injunctive or equitable relief.

     16. Indemnification.

          (a) The Executive shall continue to be indemnified under the amended and restated
Indemnification Agreement, dated as of July 11, 2000, a copy of which is attached hereto as Exhibit
B, in accordance with the terms of such agreement.

          (b) The Company agrees to continue and maintain a directors’ and officers’ liability insurance
policy covering the Executive to the extent the Company provides such coverage for its other senior
executives.

     17. Assignability; Binding Nature. This Agreement shall be binding upon and inure to
the benefit of the Parties and their respective successors, heirs (in the case of the Executive)
and assigns. Rights or obligations of the Company under this Agreement may be assigned or
transferred by the Company pursuant to a merger or consolidation in which the Company is not the
continuing entity, or the sale or liquidation of all or substantially all of the assets of the
Company, provided that the assignee or transferee is the successor to all or substantially all of
the assets of the Company and such assignee or transferee assumes the liabilities, obligations and
duties of the Company, as contained in this Agreement, either contractually or as a matter of law.
The Company further agrees that, in the event of a sale of assets or liquidation as described in
the preceding sentence, it shall take whatever action it reasonably can in order to cause such
assignee

14

 

or transferee to expressly assume the liabilities, obligations and duties of the Company
hereunder. No rights or obligations of the Executive under this Agreement may be assigned or
transferred by the Executive other than his rights to compensation and benefits, which may be
transferred only by will or operation of law.

     18. Representations.

          (a) The Company represents and warrants that it is fully authorized and empowered to enter
into this Agreement and that the performance of its obligations under this Agreement will not
violate any agreement between it and any other person, firm or organization. The Executive
represents that he knows of no agreement between him and any other person, firm or organization
that would be violated by the performance of his obligations under this Agreement.

          (b) Executive hereby represent and warrants that he is not bound by the terms of any agreement
with any previous employer or other party to refrain from competing, directly or indirectly, with
the business of such previous employer or any other party. Executive further represents and
warrants that Executive’s performance of all the terms of this Agreement and as an employee of the
Company does not and will not breach any agreement to keep in confidence proprietary information,
knowledge or data acquired by Executive in confidence or in trust prior to Executive’s employment
with the Company. Executive will not disclose to the Company or induce the Company to use any
confidential or proprietary information or material belonging to any previous employer or others.
Executive will not hereafter grant anyone any rights inconsistent with the terms of this Agreement.

     19. Entire Agreement. This Agreement contains the entire understanding and agreement
between the Parties concerning the subject matter hereof and supersedes all prior agreements,
understandings, discussions, negotiations and undertakings, whether written or oral, between the
Parties with respect thereto (including without limitation the letter agreement dated February 11,
2004); provided, however, that nothing contained herein shall modify or amend the terms of any
outstanding restricted stock or stock option granted to the Executive in a manner adverse to the
Executive. This is an integrated document.

     20. Amendment or Waiver. No provision in this Agreement may be amended unless such
amendment is agreed to in writing and signed by the Executive and an authorized officer of the
Company. No waiver by either Party of any breach by the other Party of any condition or provision
contained in this Agreement to be performed by such other Party shall be deemed a waiver of a
similar or dissimilar condition or provision at the same or any prior or subsequent time. Any
waiver must be in writing and signed by the Executive or an authorized officer of the Company, as
the case may be.

     21. Severability. In the event that any provision or portion of this Agreement shall
be determined to be invalid or unenforceable for any reason, in whole or in part, the remaining
provisions of this Agreement shall be unaffected thereby and shall remain in full force and effect
to the fullest extent permitted by law so as to achieve the purposes of this Agreement.

15

 

     22. References. In the event of the Executive’s death or a judicial determination of
his incompetence, reference in this Agreement to the Executive shall be deemed, where appropriate,
to refer to his beneficiary, estate or other legal representative.

     23. Governing Law/Jurisdiction. This Agreement shall be governed in accordance with
the laws of Massachusetts without reference to principles of conflict of laws.

     24. Notices. All notices and other communications required or permitted hereunder
shall be in writing and shall be deemed given when (a) delivered personally, (b) sent by certified
or registered mail, postage prepaid, return receipt requested or (c) delivered by overnight courier
(provided that a written acknowledgment of receipt is obtained by the overnight courier) to the
Party concerned at the address indicated below or to such changed address as such Party may
subsequently give such notice of:

	 	 	 	 	 
	 

	 	If to the Company:
	 	Thermo Fisher Scientific Inc.
	 

	 	 	 	81 Wyman Street
	 

	 	 	 	Waltham, MA 02451
	 

	 	 	 	Attention: Senior Vice President and General Counsel
	 
	 	 	 	 
	 

	 	 	 	Copy: Chairman, Compensation Committee of the Board
of Directors
	 
	 

	 	If to the Executive:
	 	Marijn Dekkers
	 

	 	 	 	c/o Thermo Fisher Scientific Inc.
	 

	 	 	 	81 Wyman Street
	 

	 	 	 	Waltham, MA 02451
	 
	 	 	 	 
	 

	 	 	 	Copy:
	 

	 	 	 	Paul J. Wessel, Esq.
	 

	 	 	 	Milbank, Tweed, Hadley & McCloy LLP
	 

	 	 	 	One Chase Manhattan Plaza
	 

	 	 	 	New York, New York 10005

     25. Headings. The headings of the sections contained in this Agreement are for
convenience only and shall not be deemed to control or affect the meaning or construction of any
provision of this Agreement.

     26. Counterparts. This Agreement may be executed in two or more counterparts.

     27. 409A Compliance. This Agreement is intended to comply with Section 409A of the
Code and shall be interpreted consistently therewith. Any provision in this Agreement that is
inconsistent with Section 409A of the Code (including any guidance thereunder) shall be amended,
with the agreement of the Executive and the Company, to the extent necessary and appropriate to
bring it into compliance with said Section 409A.

[Remainder Intentionally Left Blank]

16

 

     IN WITNESS WHEREOF, the undersigned have executed this Agreement as of the date first written
above.

	 	 	 	 	 
	 	THERMO FISHER SCIENTIFIC INC.

 	 
	 	By:  	 /s/ Stephen P. Kaufman
	 
	 	 	Stephen P. Kaufman 	 
	 	 	Chairman of the Compensation Committee of
the Board of Directors 	 
	 
	 	/s/Marijn Dekkers 
Marijn Dekkers

 
	 

17

 

EXHIBIT A

[THERMO ELECTRON LOGO]

COMPANY INFORMATION AND INVENTION AGREEMENT

     In consideration and as a condition of my employment, or if now employed, the continuation of
my employment by Thermo Electron Corporation or a subsidiary thereof (hereinafter collectively
called the “Company”) and the compensation paid therefor:

     1. I agree not to disclose to others or use for my own benefit during my employment by the
Company or thereafter any trade secrets or Company private information pertaining to any of the
actual or anticipated business of the Company or any of its customers, consultants, or licensees
acquired by me during the period of my employment, except to such an extent as may be necessary in
the ordinary course of performing my particular duties as an employee of the Company.

     2. I agree not to disclose to the Company, or to induce the Company to use, any confidential
information or material belonging to others.

     3. I understand that the making of inventions, improvements, and discoveries is one of the
incidents of my employment, or that if not I may nonetheless make inventions while employed by the
Company, and I agree to assign to Thermo Electron Corporation or its nominee my entire right,
title, and interest in any invention, idea, device, or process, whether patentable or not,
hereafter made or conceived by me solely or jointly with others during the period of my employment
by the Company in an executive, managerial, planning, technical, research, engineering, or other
capacity and which relates in any manner to the business of the Company, or relates to its actual
or planned research or development, or is suggested or results from any task assigned to me or work
performed by me for or in behalf of the Company, except any invention or idea which cannot be
assigned by the Company because of a prior agreement with                                          effective
until                                          (give name and date or write “none”).

     4. I agree, in connection with any invention, idea, device, or process covered by paragraph 3:

          (a) To disclose it promptly in writing to the proper officers or attorney of the Company.

          (b) To execute promptly, on request, patent applications and assignments thereof to Thermo
Electron or its nominees and to assist the Company in any reasonable manner to enable it to secure
a patent therefor in the United States and any foreign countries, all without further compensation
except as provided herein.

     5. I further agree that all papers and records of every kind relating to any invention or
improvement included with the terms of the Agreement, which shall at any time come into my
possession shall be the sole and exclusive property of the Company and shall be surrendered to

 

 

the Company or upon request at any other time either during or after the termination of such
employment.

     6. I further agree that the obligations and undertakings stated above in paragraph 4b shall
continue beyond the termination of my employment by the Company, but if I am called upon to render
such assistance after the termination of my employment, then I shall be entitled to a fair and
reasonable per diem in addition to reimbursement of any expenses incurred at the request of the
Company.

     7. I agree to identify in an attachment to this Agreement all inventions or ideas related to
the business or actual or planned research or development of the Company in which I have right,
title, or interest, and which were conceived either wholly or in part by me prior to my employment
by the Company but neither published nor filed in the U.S. Patent and Trademark Office.

     8. I understand that this Agreement supersedes any agreement previously executed by me
relating to the disclosure, assignment and patenting of inventions, improvements, and discoveries
made during my employment by the Company. This Agreement shall inure to the benefits of the
successors and assigns of the Company and shall be binding upon my heirs, assigns, administrators,
and representatives.

     9. I understand that this Agreement does not apply to an invention which qualifies fully under
the provisions of any statute or regulation which renders unenforceable the required assignment or
transfer of certain inventions made by an employee such as, but not limited to, Section 2870 of the
California Labor Code.

	 	 	 	 	 	 	 
	 

	 	 	 	 /s/ Marijn E. Dekkers
 

 Employee
	 	 
	 
	 	 	 	 	 	 
	 

Witness

	 	 
	 	 October 13, 2000                         
 

 Date
	 	                    

	 	 	 	 	 	 	 	 	 
	 	 	 	 	THERMO ELECTRON CORPORATION	 	 
	 
	 	 	 	 	 	 	 	 
	 

	 	 
	 	By:
	 	/s/ Seth H. Hoogasian
 

	 	 
	Witness
	 	 	 	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 
	 	 	 	 	October 13, 2000	 	 
	 	 	 	 	 	 	 
	 	 	 	 	Date	 	 

2

 

EXHIBIT B

THERMO ELECTRON CORPORATION

INDEMNIFICATION AGREEMENT

     This Agreement, made and entered into this 11th day of July, 2000 (“Agreement”), by and
between Thermo Electron Corporation, a Delaware corporation (the “Company”), and Marijn E. Dekkers
(“Indemnitee”):

     WHEREAS, highly competent persons are becoming more reluctant to serve publicly-held
corporations as directors or in other capacities unless they are provided with adequate protection
through insurance or adequate indemnification against inordinate risks of claims and actions
against them arising out of their service to, and activities on behalf of, the corporation;

     WHEREAS, uncertainties relating to the continued availability of adequate directors and
officers liability insurance (“D&O Insurance”) and uncertainties relating to indemnification have
increased the difficulty of attracting and retaining such persons;

     WHEREAS, the Board of Directors of the Company (the “Board”) has determined that the
difficulty in attracting and retaining such persons is detrimental to the best interests of the
Company’s stockholders and that the Company should act to assure such persons that there will be
increased certainty of such protection in the future;

     WHEREAS, it is reasonable, prudent and necessary for the Company to obligate itself
contractually to indemnify such persons so that they will serve or continue to serve the Company
free from undue concern that they will not be so indemnified;

     WHEREAS, Indemnitee is willing to serve, continue to serve and/or take on additional service
for or on behalf of the Company on the condition that he or she be so indemnified and that such
indemnification be so guaranteed;

     NOW, THEREFORE, in consideration of the premises and the covenants contained herein, the
Company and Indemnitee do hereby covenant and agree as follows:

     1. Services by Indemnitee. Indemnitee agrees to serve or continue to serve as a
director or officer of the Company. This Agreement shall not impose any obligation on Indemnitee
or the Company to continue Indemnitee’s position with the Company beyond any period otherwise
applicable.

     2. Indemnity. The Company shall indemnify, and shall advance Expenses (as
hereinafter defined) to, Indemnitee as provided in this Agreement and to the fullest extent
permitted by law.

     3. General. Indemnitee shall be entitled to the rights of indemnification provided
in this Section 3 if, by reason of his or her Corporate Status (as hereinafter defined), Indemnitee
is, or is threatened to be made, a party to any threatened, pending, or completed action, suit,
arbitration, alternative dispute resolution proceeding, investigation, administrative hearing or

 

 

other proceeding whether civil, criminal, administrative or investigative (other than an
action, suit or proceeding covered by Section 4 hereof). Pursuant to this Section 3, Indemnitee
shall be indemnified against Expenses, judgments, penalties, fines and/or amounts paid in
settlement incurred by Indemnitee or on his or her behalf in connection with such action, suit,
arbitration, alternative dispute resolution proceeding, investigation, administrative hearing or
other proceeding whether civil, criminal, administrative or investigative or any claim, issue or
matter therein and whether or not Indemnitee is made a party thereto, if Indemnitee acted in good
faith and in a manner Indemnitee reasonably believed to be in or not opposed to the best interests
of the Company, and, with respect to any criminal action or proceeding, had no reasonable cause to
believe his or her conduct was unlawful.

     4. Proceedings by or in the Right of the Company. In the case of any threatened,
pending or completed action, suit or proceeding by or in the right of the Company, indemnification
shall be made to the maximum extent permitted under Delaware law.

     5. Indemnification for Expenses of a Party who is Wholly or Partly Successful.
Notwithstanding any other provision of this Agreement, to the extent that Indemnitee is, by reason
of his or her Corporate Status, a party to and is successful, on the merits or otherwise, in any
action, suit, arbitration, alternative dispute resolution proceeding, investigation, administrative
hearing or other proceeding whether civil, criminal, administrative or investigative, Indemnitee
shall be indemnified against all Expenses incurred by Indemnitee or on his or her behalf in
connection therewith. If Indemnitee is not wholly successful but is successful, on the merits or
otherwise, as to one or more but less than all claims, issues or matters in such action, suit,
arbitration, alternative dispute resolution proceeding, investigation, administrative hearing or
other proceeding whether civil, criminal, administrative or investigative, the Company shall
indemnify Indemnitee against all Expenses incurred by Indemnitee or on his or her behalf in
connection with each successfully resolved claim, issue or matter. For purposes of this Section
and without limitation, the termination of any claim, issue or matter by dismissal, or withdrawal
with or without prejudice, shall be deemed to be a successful result as to such claim, issue or
matter.

     6. Advance of Expenses. The Company shall advance all Expenses incurred by or on
behalf of Indemnitee in connection with any action, suit, arbitration, alternative dispute
resolution proceeding, investigation, administrative hearing or other proceeding involving his or
her Corporate Status whether civil, criminal, administrative or investigative within twenty (20)
days after the receipt by the Company of a statement or statements from Indemnitee requesting such
advance or advances from time to time, whether prior to or after final disposition of such action,
suit, arbitration, alternative dispute resolution proceeding, investigation, administrative hearing
or other proceeding whether civil, criminal, administrative or investigative. Such statement or
statements shall reasonably evidence the Expenses incurred by Indemnitee and shall include or be
preceded or accompanied by an undertaking by or on behalf of Indemnitee to repay any Expenses
advanced if it shall ultimately be determined that Indemnitee is not entitled to be indemnified
against such Expenses, which undertaking shall be accepted by or on behalf of the Company without
reference to the financial ability of Indemnitee to make repayment.

2

 

     7. Procedure for Determination of Entitlement to Indemnification.

          (a) To obtain indemnification under this Agreement, Indemnitee shall submit to the Company a
written request, including therein or therewith such documentation and information as is reasonably
available to Indemnitee and is reasonably necessary to determine whether and to what extent
Indemnitee is entitled to indemnification. The Secretary of the Company shall, promptly upon
receipt of such a request for indemnification, advise the Board in writing that Indemnitee has
requested indemnification.

          (b) Upon written request by Indemnitee for indemnification pursuant to Section 7(a) hereof, a
determination, if required (but only to the extent required) by applicable law as a precondition to
payment, with respect to Indemnitee’s entitlement thereto shall be made in the specific case: (i)
if a Change in Control (as hereinafter defined) shall have occurred, by Independent Counsel (as
hereinafter defined) in a written opinion to the Board, a copy of which shall be delivered to
Indemnitee (unless Indemnitee shall request that such determination be made by the Board or the
stockholders, in which case the determination shall be made in the manner provided below in clauses
(ii) or (iii)); (ii) if a Change of Control shall not have occurred, (A) by the Board by a majority
vote of Disinterested Directors (as hereinafter defined), even if less than a quorum, or (B) by a
committee of Disinterested Directors designated by a majority vote of Disinterested Directors, even
if less than a quorum, or (C) if the Disinterested Directors so direct, by Independent Counsel in a
written opinion to the Board, a copy of which shall be delivered to Indemnitee or (D) by the
stockholders of the Company; or (iii) as provided in Section 8(b) of this Agreement; and, if it is
so determined that Indemnitee is entitled to indemnification, payment to Indemnitee shall be made
within ten (10) days after such determination. Indemnitee shall cooperate with the person, persons
or entity making such determination with respect to Indemnitee’s entitlement to indemnification,
including providing to such person, persons or entity upon reasonable advance request any
documentation or information which is not privileged or otherwise protected from disclosure and
which is reasonably available to Indemnitee and reasonably necessary to such determination. Any
costs or expenses (including attorney’s fees and disbursements) incurred by Indemnitee in so
cooperating shall be borne by the Company (irrespective of the determination as to Indemnitee’s
entitlement to indemnification) and the Company hereby indemnifies and agrees to hold Indemnitee
harmless therefrom.

          (c) In the event the determination of entitlement to indemnification is to be made by
Independent Counsel pursuant to Section 7(b) of this Agreement, the Independent Counsel shall be
selected as provided in this Section 7(c). If a Change of Control shall not have occurred, the
Independent Counsel shall be selected by the Board, and the Company shall give written notice to
Indemnitee advising him or her of the identity of the Independent Counsel so selected. If a Change
of Control shall have occurred, the Independent Counsel shall be selected by Indemnitee (unless
Indemnitee shall request that such selection be made by the Board, in which event the preceding
sentence shall apply), and Indemnitee shall give written notice to the Company advising it of the
identity of the Independent Counsel so selected. In either event, Indemnitee or the Company, as
the case may be, may, within seven (7) days after such written notice of selection shall have been
given, deliver to the Company or to Indemnitee, as the case may be, a written objection to such
selection. Such objection may be asserted only on the ground that the Independent Counsel so
selected does not meet the requirements of “Independent

3

 

Counsel” as defined in Section 14 of this Agreement, and the objection shall set forth with
particularity the factual basis of such assertion. If such written objection is made, the
Independent Counsel so selected may not serve as Independent Counsel unless and until a court has
determined that such objection is without merit. If, within twenty (20) days after submission by
Indemnitee of a written request for indemnification pursuant to Section 7(a) hereof, no Independent
Counsel shall have been selected or if selected, shall have been objected to, in accordance with
this Section 7(c), either the Company or Indemnitee may petition the Court of Chancery of the State
of Delaware or other court of competent jurisdiction for resolution of any objection which shall
have been made by the Company or Indemnitee to the other’s selection of Independent Counsel and/or
for the appointment as Independent Counsel of a person selected by the Court or by such other
person as the Court shall designate, and the person with respect to whom an objection is favorably
resolved or the person so appointed shall act as Independent Counsel under Section 7(b) hereof.
The Company shall pay reasonable fees and expenses of Independent Counsel incurred in connection
with its acting in such capacity pursuant to Section 7(b) hereof. The Company shall pay any and
all reasonable fees and expenses incident to the procedures of this Section 7(c), regardless of the
manner in which such Independent Counsel was selected or appointed. Upon the due commencement of
any judicial proceeding or arbitration pursuant to Section 9(a) of this Agreement, Independent
Counsel shall be discharged and relieved of any further responsibility in such capacity (subject to
the applicable standards of professional conduct then prevailing).

     8. Presumptions and Effect of Certain Proceedings.

          (a) If a Change of Control shall have occurred, in making a determination with respect to
entitlement to indemnification hereunder, the person, persons or entity making such determination
shall presume that Indemnitee is entitled to indemnification under this Agreement if Indemnitee has
submitted a request for indemnification in accordance with Section 7(a) of this Agreement, and the
Company shall have the burden of proof to overcome that presumption in connection with the making
by any person, persons or entity of any determination contrary to that presumption.

          (b) If the person, persons or entity empowered or selected under Section 7 of this Agreement
to determine whether Indemnitee is entitled to indemnification shall not have made such
determination within sixty (60) days after receipt by the Company of the request therefor, the
requisite determination of entitlement to indemnification shall be deemed to have been made and
Indemnitee shall be entitled to such indemnification, absent (i) a misstatement by Indemnitee of a
material fact, or an omission of a material fact necessary to make Indemnitee’s statement not
materially misleading, in connection with the request for indemnification, or (ii) a prohibition of
such indemnification under applicable law; provided, however, that such 60-day period may be
extended for a reasonable time, not to exceed an additional thirty (30) days, if the person,
persons or entity making the determination with respect to entitlement to indemnification in good
faith requires such additional time for the obtaining or evaluating of documentation and/or
information relating thereto; and provided, further, that the foregoing provisions of this Section
8(b) shall not apply (i) if the determination of entitlement to indemnification is to be made by
the stockholders pursuant to Section 7(b) of this Agreement and if (A) within fifteen (15) days
after receipt by the Company of the request for such determination the Board has resolved to submit
such determination to the stockholders for their consideration at an annual

4

 

 meeting thereof to be held within one hundred twenty (120) days after such receipt and such
determination is made thereat, or (B) a special meeting of stockholders is called within fifteen
(15) days after such receipt for the purpose of making such determination, such meeting is held for
such purpose within one hundred five (105) days after having been so called and such determination
is made thereat, or (ii) if the determination of entitlement to indemnification is to be made by
Independent Counsel pursuant to Section 7(b) of this Agreement.

          (c) The termination of any action, suit, arbitration, alternative dispute resolution
proceeding, investigation, administrative hearing or other proceeding whether civil, criminal,
administrative or investigative or of any claim, issue or matter therein by judgment, order,
settlement or conviction, or upon a plea of nolo contendere or its equivalent, shall not (except as
otherwise expressly provided in this Agreement) of itself adversely affect the right of Indemnitee
to indemnification or create a presumption that Indemnitee did not act in good faith and in a
manner which Indemnitee reasonably believed to be in or not opposed to the best interests of the
Company or, with respect to any criminal action or proceeding, that Indemnitee had reasonable cause
to believe that his or her conduct was unlawful.

     9. Remedies of Indemnitee.

          (a) In the event that (i) a determination is made pursuant to Section 7 of this Agreement that
Indemnitee is not entitled to indemnification under this Agreement, (ii) advancement of Expenses is
not timely made pursuant to Section 6 of this Agreement, (iii) the determination of entitlement to
indemnification is to be by Independent Counsel pursuant to Section 7(b) of this Agreement and such
determination shall not have been made and delivered in a written opinion within ninety (90) days
after receipt by the Company of the request for indemnification, (iv) payment of indemnification is
not made pursuant to Section 5 of this Agreement within ten (10) days after receipt by the Company
of a written request therefor, or (v) payment of indemnification is not made within ten (10) days
after a determination has been made that Indemnitee is entitled to indemnification or such
determination is deemed to have been made pursuant to Section 8 of this Agreement, Indemnitee shall
be entitled to an adjudication in an appropriate court of the State of Delaware, or in any other
court of competent jurisdiction, of Indemnitee’s entitlement to such indemnification or advancement
of Expenses. Alternatively, Indemnitee, at his or her option, may seek an award in arbitration to
be conducted by a single arbitrator pursuant to the rules of the American Arbitration Association.
Indemnitee shall commence such proceeding seeking an adjudication or an award in arbitration within
one hundred eighty (180) days following the date on which Indemnitee first has the right to
commence such proceeding pursuant to this Section 9(a). The Company shall not oppose Indemnitee’s
right to seek any such adjudication or award in arbitration.

          (b) In the event that a determination shall have been made pursuant to Section 7 of this
Agreement that Indemnitee is not entitled to indemnification, any judicial proceeding or
arbitration commenced pursuant to this Section 9 shall be conducted in all respects as a de novo
trial, or arbitration, on the merits and Indemnitee shall not be prejudiced by reason of that
adverse determination. If a Change of Control shall have occurred, in any judicial proceeding or
arbitration commenced pursuant to this Section 9 the Company shall have the burden of proving that
Indemnitee is not entitled to indemnification or advancement of Expenses, as the case may be.

5

 

          (c) If a determination shall have been made or deemed to have been made pursuant to Section 7
or 8 of this Agreement that Indemnitee is entitled to indemnification, the Company shall be bound
by such determination in any judicial proceeding or arbitration commenced pursuant to this Section
9, absent (i) a misstatement by Indemnitee of a material fact, or an omission of a material fact
necessary to make Indemnitee’s statement not materially misleading, in connection with the request
for indemnification, or (ii) a prohibition of such indemnification under applicable law.

          (d) The Company shall be precluded from asserting in any judicial proceeding or arbitration
commenced pursuant to this Section 9 that the procedures and presumptions of this Agreement are not
valid, binding and enforceable and shall stipulate in any such court or before any such arbitrator
that the Company is bound by all the provisions of this Agreement.

          (e) In the event that Indemnitee, pursuant to this Section 9, seeks a judicial adjudication of
or an award in arbitration to enforce Indemnitee’s rights under, or to recover damages for breach
of, this Agreement, Indemnitee shall be entitled to recover from the Company, and shall be
indemnified by the Company against, any and all expenses (of the types described in the definition
of Expenses in Section 14 of this Agreement) actually and reasonably incurred by him or her in such
judicial adjudication or arbitration, but only if Indemnitee prevails therein. If it shall be
determined in said judicial adjudication or arbitration that Indemnitee is entitled to receive part
but not all of the indemnification or advancement of expenses sought, the expenses incurred by
Indemnitee in connection with such judicial adjudication or arbitration shall be appropriately
prorated.

     10. Security. To the extent requested by Indemnitee and approved by the Board, the
Company shall at any time and from time to time provide security to Indemnitee for the Company’s
obligations hereunder through an irrevocable bank line of credit, funded trust or other collateral.
Any such security, once provided to Indemnitee, may not be revoked or released without the prior
written consent of Indemnitee.

     11. Non-Exclusivity; Duration of Agreement; Insurance; Subrogation.

          (a) The rights of indemnification and to receive advancement of Expenses as provided by this
Agreement are in addition to and shall not be deemed exclusive of any other rights to which
Indemnitee may at any time be entitled under applicable law, the Company’s certificate of
incorporation or by-laws, any other agreement, a vote of stockholders or a resolution of directors,
or otherwise. Without limiting the foregoing, the Company shall indemnify Indemnitee to the
fullest extent permitted under Delaware law. This Agreement shall continue until and terminate
upon the later of (a) ten (10) years after the date that Indemnitee shall have ceased to serve as a
director or officer of the Company or director, officer or other fiduciary of any other
corporation, partnership, joint venture, trust, employee benefit plan or other enterprise which
Indemnitee served at the request of the Company; or (b) the final termination of all pending
actions, suits, arbitrations, alternative dispute resolution proceedings, investigations,
administrative hearings or other proceedings whether civil, criminal, administrative or
investigative in respect of which Indemnitee is granted rights of indemnification or advancement of
Expenses hereunder and of any proceeding commenced by Indemnitee pursuant to Section 9 of this
Agreement relating thereto. This Agreement shall be

6

 

 binding upon the Company and its successors and assigns and shall inure to the benefit of
Indemnitee and his or her heirs, executors and administrators.

          (b) To the extent that the Company maintains D&O Insurance, Indemnitee shall be covered by
such D&O Insurance in accordance with its terms to the maximum extent of the coverage available for
any director or officer under such policy or policies.

          (c) In the event of any payment under this Agreement, the Company shall be subrogated to the
extent of such payment to all of the rights of recovery of Indemnitee, who shall execute all papers
required and take all action necessary to secure such rights, including execution of such documents
as are necessary to enable the Company to bring suit to enforce such rights.

          (d) The Company shall not be liable under this Agreement to make any payment of amounts
otherwise indemnifiable hereunder if and to the extent that Indemnitee has otherwise actually
received such payment under any insurance policy, contract, agreement or otherwise.

     12. Severability; Reformation. If any provision or provisions of this Agreement shall
be held to be invalid, illegal or unenforceable for any reason whatsoever: (a) the validity,
legality and enforceability of the remaining provisions of this Agreement (including without
limitation, each portion of any Section of this Agreement containing any such provision held to be
invalid, illegal or unenforceable, that is not itself invalid, illegal or unenforceable) shall not
in any way be affected or impaired thereby; and (b) to the fullest extent possible, the provisions
of this Agreement (including, without limitation, each portion of any Section of this Agreement
containing any such provision held to be invalid, illegal or unenforceable, that is not itself
invalid, illegal or unenforceable) shall be construed so as to give effect to the intent manifested
by the provision held invalid, illegal or unenforceable.

     13. Exception to Right of Indemnification or Advancement of Expenses. Notwithstanding
any other provision of this Agreement, Indemnitee shall not be entitled to indemnification or
advancement of Expenses under this Agreement with respect to any action, suit or proceeding, or any
claim therein, initiated, brought or made by Indemnitee (i) against the Company, unless a Change in
Control shall have occurred, or (ii) against any person other than the Company, unless approved in
advance by the Board.

     14. Definitions. For purposes of this Agreement:

          (a) “Change in Control” means an event or occurrence set forth in any one or more of
subsection (i) through (iv) below (including an event or occurrence that constitutes a Change in
Control under one of such subsections but is specifically exempted from another such subsection):

          (i) the acquisition by an individual, entity or group (within the meaning of Section
13(d)(3) or 14(d)(2) of the Securities Exchange Act of 1934, as amended (the “Exchange
Act”)) (a “Person”) of beneficial ownership of any capital stock of the Company if, after
such acquisition, such Person beneficially owns (within the meaning of Rule 13d-3
promulgated under the Exchange Act) 40% or more of either (A)

7

 

the then-outstanding shares of common stock of the Company (the “Outstanding Company
Common Stock”) or (B) the combined voting power of the then-outstanding securities of the
Company entitled to vote generally in the election of directors (the “Outstanding Company
Voting Securities”); provided, however, that for purposes of this subsection (i), the
following acquisitions shall not constitute a Change in Control: (A) any acquisition by the
Company, (B) any acquisition by any employee benefit plan (or related trust) sponsored or
maintained by the Company or any corporation controlled by the Company, or (C) any
acquisition by any corporation pursuant to a transaction which complies with clauses (A) and
(B) of subsection (iii) of this Section 14(a); or

          (ii) such time as the Continuing Directors (as defined below) do not constitute a
majority of the Board (or, if applicable, the Board of Directors of a successor corporation
to the Company), where the term “Continuing Director” means at any date a member of the
Board (A) who was a member of the Board on September 23, 1999 or (B) who was nominated or
elected subsequent to such date by at least a majority of the directors who were Continuing
Directors at the time of such nomination or election; provided, however, that there shall be
excluded form this clause (B) any individual whose initial assumption of office occurred as
a result of an actual or threatened election contest with respect to the election or removal
of directors or other actual or threatened solicitation of proxies or consents, by or on
behalf of a person other than the Board; or

          (iii) the consummation of a merger, consolidation, reorganization, recapitalization or
statutory share exchange involving the Company or a sale or other disposition of all or
substantially all of the assets of the Company in one or a series of transactions (a
“Business Combination”), unless, immediately following such Business Combination, each of
the following two conditions is satisfied: (A) all or substantially all of the individuals
and entities who were the beneficial owners of the Outstanding Company Common Stock and
Outstanding Company Voting Securities immediately prior to such Business Combination
beneficially own, directly or indirectly, more than 60% of the then-outstanding shares of
common stock and the combined voting power of the then-outstanding securities entitled to
vote generally in the election of directors, respectively, of the resulting or acquiring
corporation in such Business Combination (which shall include, without limitation, a
corporation which as a result of such transaction owns the Company or substantially all of
the Company’s assets either directly or through one or more subsidiaries) (such resulting or
acquiring corporation is referred to herein as the “Acquiring Corporation”) in substantially
the same proportions as their ownership, immediately prior to such Business Combination, of
the Outstanding Company Common Stock and Outstanding Company Voting Securities,
respectively; and (B) no Person (excluding the Acquiring Corporation or any employee benefit
plan (or related trust) maintained or sponsored by the Company or by the Acquiring
Corporation) beneficially owns, directly or indirectly, 40% or more of the then outstanding
 shares of common stock of the Acquiring Corporation, or of the combined voting power of the
then-outstanding securities of such corporation entitled to vote generally in the election
of directors; or

          (iv) approval by the stockholders of the Company of a complete liquidation or
dissolution of the Company; or

8

 

          (b) “Corporate Status” describes the status of a person who is or was or has agreed to become
a director of the Company, or is or was an officer or fiduciary of the Company or a director,
officer or fiduciary of any other corporation, partnership, joint venture, trust, employee benefit
plan or other enterprise which such person is or was serving at the request of the Company.

          (c) “Disinterested Director” means a director of the Company who is not and was not a party to
the action, suit, arbitration, alternative dispute resolution proceeding, investigation,
administrative hearing or any other proceeding whether civil, criminal, administrative or
investigative in respect of which indemnification is sought by Indemnitee.

          (d) “Expenses” shall include all reasonable attorneys’ fees, retainers, court costs,
transcript costs, fees and expenses of experts, including but not limited to fees and expenses of
investment bankers and/or consultants which the Company has authorized Indemnitee to hire and
attorneys for such experts, travel expenses, duplicating costs, printing and binding costs,
telephone charges, postage, deliver service fees, a reasonable per diem fee to compensate
Indemnitee for his or her professional time and all other disbursements or expenses of the types
customarily incurred in connection with prosecuting, defending, preparing to prosecute or defend or
investigating an action, suit, arbitration, alternative dispute resolution proceeding,
investigation, administrative hearing or any other proceeding whether civil, criminal,
administrative or investigative.

          (e) “Independent Counsel” means a law firm, with over 100 lawyers, that is experienced in
matters of corporation law and neither currently is, nor in the past five years has been, retained
to represent: (i) the Company (including any subsidiary thereof) or Indemnitee in any matter
material to either such party or (ii) any other party to the action, suit, arbitration, alternative
dispute resolution proceeding, investigation, administrative hearing or any other proceeding
whether civil, criminal, administrative or investigative giving rise to a claim for indemnification
hereunder. Notwithstanding the foregoing, the term “Independent Counsel” shall not include any
person who, under the applicable standards of professional conduct then prevailing, would have a
conflict of interest in representing either the Company or Indemnitee in an action to determine
Indemnitee’s rights under this Agreement.

     15. Headings. The headings of the paragraphs of this Agreement are inserted for
convenience only and shall not be deemed to constitute part of this Agreement or to affect the
construction thereof.

     16. Modification and Waiver. This Agreement may be amended from time to time to
reflect changes in Delaware law or for other reasons. No supplement, modification or amendment of
this Agreement shall be binding unless executed in writing by both of the parties hereto. No
waiver of any of the provisions of this Agreement shall be deemed or shall constitute a waiver of
any other provision hereof (whether or not similar) nor shall such waiver constitute a continuing
waiver.

     17. Notice by Indemnitee. Indemnitee agrees promptly to notify the Company in writing
upon being served with any summons, citation, subpoena, complaint, indictment, information or other
document relating to any matter which may be subject to indemnification or

9

 

advancement of Expenses covered hereunder; provided, however, that the failure to give any
such notice shall not disqualify Indemnitee from indemnification hereunder.

     18. Notices. All notices, requests, demands and other communications hereunder shall
be in writing and shall be deemed to have been duly given if (i) delivered by hand and receipted
for by the party to whom said notice or other communication shall have been directed, or (ii)
mailed by certified or registered mail with postage prepaid, on the third business day after the
date on which it is so mailed:

          (a) If to Indemnitee, to: The address shown beneath his or her signature on the last page
hereof

          (b) If to the Company to: Thermo Electron Corporation 81 Wyman Street P.O. Box 9046 Waltham,
MA 02454-9046 Attn: Corporate Secretary or to such other address as may have been furnished to
Indemnitee by the Company or to the Company by Indemnitee, as the case may be.

     19. Governing Law. The parties agree that this Agreement shall be governed by, and
construed and enforced in accordance with, the laws of the State of Delaware.

     20. Entire Agreement. This agreement sets forth the entire agreement of the parties
hereto in respect of the subject matter contained herein and supersedes all prior agreements,
promises, covenants, arrangements, communications, representations or warranties, whether oral or
written, by any officer, employee or representative of any party hereto in respect of the subject
matter contained herein; and any prior agreement of the parties hereto in respect of the subject
matter contained herein is hereby terminated and cancelled.

     IN WITNESS WHEREOF, the parties hereto have executed this Agreement on the day and year first
above written.

	 	 	 	 	 	 	 	 	 	 	 
	Attest:	 	 	 	THERMO ELECTRON CORPORATION	 	 
	 
	 	 	 	 	 	 	 	 	 	 
	By:

	 	/s/ Sandra L. Lambert     
 

	 	              
	 	 By:
	 	/s/ Seth H. Hoogasian                         
 

	 	 
	 

	 	Sandra L. Lambert
	 	 	 	 	 	Seth H. Hoogasian	 	 
	 

	 	Vice President, Secretary
	 	 	 	 	 	Vice President and General Counsel	 	 
	 
	 	 	 	 	 	 	 	 	 	 
	 	 	 	 	 	 	INDEMNITEE	 	 
	 
	 	 	 	 	 	 	 	 	 	 
	 	 	 	 	 	 	/s/ Marijn E. Dekkers  	 	 
	 	 	 	 	 	 	 	 	 
	 	 	 	 	 	 	Marijn E. Dekkers	 	 
	 
	 	 	 	 	 	 	 	 	 	 
	 	 	 	 	 	 	Address:	 	 

10

 

EXHIBIT
C
EXECUTIVE RETENTION AGREEMENT

     THIS AGREEMENT by and between THERMO ELECTRON CORPORATION, a Delaware corporation (the
“Company”), and Marijn E. Dekkers (the “Executive”) is made as of November 21, 2002 (the “Effective
Date”).

     WHEREAS, the Company recognizes that, as is the case with many publicly-held corporations, the
possibility of a change in control of the Company exists and that such possibility, and the
uncertainty and questions which it may raise among key personnel, may result in the departure or
distraction of key personnel to the detriment of the Company and its stockholders;

     WHEREAS, the Board of Directors of the Company (the “Board”) has determined that appropriate
steps should be taken to reinforce and encourage the continued employment and dedication of the
Company’s key personnel without distraction from the possibility of a change in control of the
Company and related events and circumstances; and

     NOW, THEREFORE, as an inducement for and in consideration of the Executive remaining in its
employ, the Company agrees that the Executive shall receive the severance benefits set forth in
this Agreement in the event the Executive’s employment with the Company is terminated under the
circumstances described below subsequent to a Change in Control (as defined in Section 1.1).

1. Key Definitions.

     As used herein, the following terms shall have the following respective meanings:

     1.1 “Change in Control” means an event or occurrence set forth in any one or more of
subsections (a) through (d) below (including an event or occurrence that constitutes a Change in
Control under one of such subsections but is specifically exempted from another such subsection):

          (a) the acquisition by an individual, entity or group (within the meaning of Section 13(d)(3)
or 14(d)(2) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)) (a “Person”)
of beneficial ownership of any capital stock of the Company if, after such acquisition, such Person
beneficially owns (within the meaning of Rule 13d-3 promulgated under the Exchange Act) 40% or more
of either (i) the then-outstanding shares of common stock of the Company (the “Outstanding Company
Common Stock”) or (ii) the combined voting power of the then-outstanding securities of the Company
entitled to vote generally in the election of directors (the “Outstanding Company Voting
Securities”); provided, however, that for purposes of this subsection (a), the following
acquisitions shall not constitute a Change in Control: (i) any acquisition by the Company, (ii) any
acquisition by any employee benefit plan (or related trust) sponsored or maintained by the Company
or any corporation controlled by the Company, or (iii) any acquisition by any corporation pursuant
to a transaction which complies with clauses (i) and (ii) of subsection (c) of this Section 1.1; or

          (b) such time as the Continuing Directors (as defined below) do not constitute a majority of
the Board (or, if applicable, the Board of Directors of a successor corporation to the

 

Company), where the term “Continuing Director” means at any date a member of the Board (i) who
was a member of the Board on the date of the execution of this Agreement or (ii) who was nominated
or elected subsequent to such date by at least a majority of the directors who were Continuing
Directors at the time of such nomination or election or whose election to the Board was recommended
or endorsed by at least a majority of the directors who were Continuing Directors at the time of
such nomination or election; provided, however, that there shall be excluded from this clause (ii)
any individual whose initial assumption of office occurred as a result of an actual or threatened
election contest with respect to the election or removal of directors or other actual or threatened
solicitation of proxies or consents, by or on behalf of a person other than the Board; or

          (c) the consummation of a merger, consolidation, reorganization, recapitalization or statutory
share exchange involving the Company or a sale or other disposition of all or substantially all of
the assets of the Company in one or a series of transactions (a “Business Combination”), unless,
immediately following such Business Combination, each of the following two conditions is satisfied:
(i) all or substantially all of the individuals and entities who were the beneficial owners of the
Outstanding Company Common Stock and Outstanding Company Voting Securities immediately prior to
such Business Combination beneficially own, directly or indirectly, more than 60% of the
then-outstanding shares of common stock and the combined voting power of the then-outstanding
securities entitled to vote generally in the election of directors, respectively, of the resulting
or acquiring corporation in such Business Combination (which shall include, without limitation, a
corporation which as a result of such transaction owns the Company or substantially all of the
Company’s assets either directly or through one or more subsidiaries) (such resulting or acquiring
corporation is referred to herein as the “Acquiring Corporation”) in substantially the same
proportions as their ownership, immediately prior to such Business Combination, of the Outstanding
Company Common Stock and Outstanding Company Voting Securities, respectively; and (ii) no Person
(excluding the Acquiring Corporation or any employee benefit plan (or related trust) maintained or
sponsored by the Company or by the Acquiring Corporation) beneficially owns, directly or
indirectly, 40% or more of the then outstanding shares of common stock of the Acquiring
Corporation, or of the combined voting power of the then-outstanding securities of such corporation
entitled to vote generally in the election of directors; or

          (d) approval by the stockholders of the Company of a complete liquidation or dissolution of
the Company.

     1.2 “Change in Control Date” means the first date during the Term (as defined in Section 2) on
which a Change in Control occurs. Anything in this Agreement to the contrary notwithstanding, if
(a) a Change in Control occurs, (b) the Executive’s employment with the Company is terminated prior
to the date on which the Change in Control occurs, and (c) it is reasonably demonstrated by the
Executive that such termination of employment (i) was at the request of a third party who has taken
steps reasonably calculated to effect a Change in Control or (ii) otherwise arose in connection
with or in anticipation of a Change in Control, then for all purposes of this Agreement the “Change
in Control Date” shall mean the date immediately prior to the date of such termination of
employment.

2

 

     1.3 “Cause” means the Executive’s willful engagement in illegal conduct or gross misconduct
after the Change in Control Date which is materially and demonstrably injurious to the Company.
For purposes of this Section 1.3, no act or failure to act by the Executive shall be considered
“willful” unless it is done, or omitted to be done, in bad faith and without reasonable belief that
the Executive’s action or omission was in the best interests of the Company.

     1.4 “Good Reason” means the occurrence, without the Executive’s written consent, of any of the
events or circumstances set forth in clauses (a) through (g) below. Notwithstanding the occurrence
of any such event or circumstance, such occurrence shall not be deemed to constitute Good Reason
if, prior to the Date of Termination specified in the Notice of Termination (each as defined in
Section 3.2(a)) given by the Executive in respect thereof, such event or circumstance has been
fully corrected and the Executive has been reasonably compensated for any losses or damages
resulting therefrom (provided that such right of correction by the Company shall only apply to the
first Notice of Termination for Good Reason given by the Executive).

          (a) the assignment to the Executive of duties inconsistent in any material respect with the
Executive’s position (including status, offices, titles and reporting requirements), authority or
responsibilities in effect immediately prior to the earliest to occur of (i) the Change in Control
Date, (ii) the date of the execution by the Company of the initial written agreement or instrument
providing for the Change in Control or (iii) the date of the adoption by the Board of Directors of
a resolution providing for the Change in Control (with the earliest to occur of such dates referred
to herein as the “Measurement Date”) or a material diminution in such position, authority or
responsibilities;

          (b) a reduction in the Executive’s annual base salary as in effect on the Measurement Date or
as the same was or may be increased thereafter from time to time;

          (c) the failure by the Company to (i) continue in effect any material compensation or benefit
plan or program (including without limitation any life insurance, medical, health and accident or
disability plan and any vacation or automobile program or policy) (a “Benefit Plan”) in which the
Executive participates or which is applicable to the Executive immediately prior to the Measurement
Date, unless an equitable arrangement (embodied in an ongoing substitute or alternative plan) has
been made with respect to such plan or program, (ii) continue the Executive’s participation therein
(or in such substitute or alternative plan) on a basis not materially less favorable than the basis
existing immediately prior to the Measurement Date (iii) award cash bonuses to the Executive in
amounts and in a manner substantially consistent with past practice in light of the Company’s
financial performance or (iv) continue to provide any material fringe benefit enjoyed by Executive
immediately prior to the Measurement Date;

          (d) a change by the Company in the location at which the Executive performs his principal
duties for the Company to a new location that is both (i) outside a radius of 50 miles from the
Executive’s principal residence immediately prior to the Measurement Date and (ii) more than 30
miles from the location at which the Executive performed his principal duties for the Company
immediately prior to the Measurement Date; or a requirement by the Company that

3

 

the Executive travel on Company business to a substantially greater extent than required
immediately prior to the Measurement Date;

          (e) the failure of the Company to obtain the agreement from any successor to the Company to
assume and agree to perform this Agreement, as required by Section 6.1;

          (f) a purported termination of the Executive’s employment which is not effected pursuant to a
Notice of Termination satisfying the requirements of Section 3.2(a); or

          (g) any failure of the Company to pay or provide to the Executive any portion of the
Executive’s compensation or benefits due under any Benefit Plan within seven days of the date such
compensation or benefits are due, or any material breach by the Company of this Agreement or any
employment agreement with the Executive.

     The Executive’s right to terminate his employment for Good Reason shall not be affected by his
incapacity due to physical or mental illness.

     1.5 “Disability” means the Executive’s absence from the full-time performance of the
Executive’s duties with the Company for 180 consecutive calendar days as a result of incapacity due
to mental or physical illness which is determined to be total and permanent by a physician selected
by the Company or its insurers and acceptable to the Executive or the Executive’s legal
representative.

2. Term of Agreement.

     This Agreement, and all rights and obligations of the parties hereunder, shall take effect
upon the Effective Date and shall expire upon the first to occur of (a) the expiration of the Term
(as defined below) if a Change in Control has not occurred during the Term, (b) the date 18 months
after the Change in Control Date, if the Executive is still employed by the Company as of such
later date, or (c) the fulfillment by the Company of all of its obligations under Sections 4 and
5.2 if the Executive’s employment with the Company terminates within 18 months following the Change
in Control Date. “Term” shall mean the period commencing as of the Effective Date and continuing
in effect through December 31, 2003; provided, however, that commencing on January 1, 2003 and each
January 1, thereafter, the Term shall be automatically extended for one additional year unless, not
later than 90 days prior to the scheduled expiration of the Term (or any extension thereof), the
Company shall have given the Executive written notice that the Term will not be extended.

3. Employment Status; Termination Following Change in Control.

     3.1 Not an Employment Contract. The Executive acknowledges that this Agreement does
not constitute a contract of employment or impose on the Company any obligation to retain the
Executive as an employee and that this Agreement does not prevent the Executive from terminating
employment at any time. If the Executive’s employment with the Company terminates for any reason
and subsequently a Change in Control shall occur, the Executive shall not be entitled to any
benefits hereunder except as otherwise provided pursuant to Section 1.2.

4

 

     3.2 Termination of Employment.

          (a) If the Change in Control Date occurs during the Term, any termination of the Executive’s
employment by the Company or by the Executive within 18 months following the Change in Control Date
(other than due to the death of the Executive) shall be communicated by a written notice to the
other party hereto (the “Notice of Termination”), given in accordance with Section 7. Any Notice
of Termination shall: (i) indicate the specific termination provision (if any) of this Agreement
relied upon by the party giving such notice, (ii) to the extent applicable, set forth in reasonable
detail the facts and circumstances claimed to provide a basis for termination of the Executive’s
employment under the provision so indicated and (iii) specify the Date of Termination (as defined
below). The effective date of an employment termination (the “Date of Termination”) shall be the
close of business on the date specified in the Notice of Termination (which date may not be less
than 15 days or more than 120 days after the date of delivery of such Notice of Termination), in
the case of a termination other than one due to the Executive’s death, or the date of the
Executive’s death, as the case may be. In the event the Company fails to satisfy the requirements
of Section 3.2(a) regarding a Notice of Termination, the purported termination of the Executive’s
employment pursuant to such Notice of Termination shall not be effective for purposes of this
Agreement.

          (b) The failure by the Executive or the Company to set forth in the Notice of Termination any
fact or circumstance which contributes to a showing of Good Reason or Cause shall not waive any
right of the Executive or the Company, respectively, hereunder or preclude the Executive or the
Company, respectively, from asserting any such fact or circumstance in enforcing the Executive’s or
the Company’s rights hereunder.

          (c) Any Notice of Termination for Cause given by the Company must be given within 90 days of
the occurrence of the event(s) or circumstance(s) which constitute(s) Cause. Prior to any Notice
of Termination for Cause being given (and prior to any termination for Cause being effective), the
Executive shall be entitled to a hearing before the Board of Directors of the Company at which he
may, at his election, be represented by counsel and at which he shall have a reasonable opportunity
to be heard. Such hearing shall be held on not less than 15 days prior written notice to the
Executive stating the Board of Directors’ intention to terminate the Executive for Cause and
stating in detail the particular event(s) or circumstance(s) which the Board of Directors believes
constitutes Cause for termination.

          (d) Any Notice of Termination for Good Reason given by the Executive must be given within 90
days of the occurrence of the event(s) or circumstance(s) which constitute(s) Good Reason.

4. Benefits to Executive.

     4.1 Stock Acceleration. If the Change in Control Date occurs during the Term, then,
effective upon the Change in Control Date, (a) each outstanding option to purchase shares of Common
Stock of the Company held by the Executive shall become immediately exercisable in full and will no
longer be subject to a right of repurchase by the Company and (b) each outstanding restricted stock
award shall be deemed to be fully vested and will no longer be subject to a right of repurchase by
the Company.

5

 

     4.2 Compensation. If the Change in Control Date occurs during the Term and the
Executive’s employment with the Company terminates within 18 months following the Change in Control
Date, the Executive shall be entitled to the following benefits:

          (a) Termination Without Cause or for Good Reason. If the Executive’s employment with
the Company is terminated by the Company (other than for Cause, Disability or Death) or by the
Executive for Good Reason within 18 months following the Change in Control Date, then the Executive
shall be entitled to the following benefits:

          (i) the Company shall pay to the Executive in a lump sum in cash within 30 days after
the Date of Termination the aggregate of the following amounts:

(1) the sum of (A) the Executive’s base salary through the Date of Termination, (B)
the product of (x) the annual bonus paid or payable (including any bonus or portion
thereof which has been earned but deferred) for the most recently completed fiscal
year and (y) a fraction, the numerator of which is the number of days in the current
fiscal year through the Date of Termination, and the denominator of which is 365 and
(C) the amount of any compensation previously deferred by the Executive (together
with any accrued interest or earnings thereon) and any accrued vacation pay, in each
case to the extent not previously paid (the sum of the amounts described in clauses
(A), (B), and (C) shall be hereinafter referred to as the “Accrued Obligations”);
and

(2) the amount equal to (A) three multiplied by (B) the sum of (x) the Executive’s
highest annual base salary in any twelve-month period (on a rolling basis) during
the five-year period prior to the Change in Control Date and (y) the Executive’s
highest annual bonus in any twelve-month period (on a rolling basis) during the
five-year period prior to the Change in Control Date.

          (ii) for three years after the Date of Termination, or such longer period as may be
provided by the terms of the appropriate plan, program, practice or policy, the Company
shall continue to provide benefits to the Executive and the Executive’s family at least
equal to those which would have been provided to them if the Executive’s employment had not
been terminated, in accordance with the applicable Benefit Plans in effect on the
Measurement Date or, if more favorable to the Executive and his family, in effect generally
at any time thereafter with respect to other peer executives of the Company and its
affiliated companies; provided, however, that if the Executive becomes reemployed with
another employer and is eligible to receive a particular type of benefits (e.g., health
insurance benefits) from such employer on terms at least as favorable to the Executive and
his family as those being provided by the Company, then the Company shall no longer be
required to provide those particular benefits to the Executive and his family;

          (iii) to the extent not previously paid or provided, the Company shall timely pay or
provide to the Executive any other amounts or benefits required to be paid or provided or
which the Executive is eligible to receive following the Executive’s termination of
employment under any plan, program, policy, practice, contract or

6

 

agreement of the Company and its affiliated companies (such other amounts and benefits
shall be hereinafter referred to as the “Other Benefits”); and

          (iv) for purposes of determining eligibility (but not the time of commencement of
benefits) of the Executive for retiree benefits to which the Executive is entitled, the
Executive shall be considered to have remained employed by the Company until three years
after the Date of Termination.

          (b) Resignation without Good Reason; Termination for Death or Disability. If the
Executive voluntarily terminates his employment with the Company within 18 months following the
Change in Control Date, excluding a termination for Good Reason, or if the Executive’s employment
with the Company is terminated by reason of the Executive’s death or Disability within 18 months
following the Change in Control Date, then the Company shall (i) pay the Executive (or his estate,
if applicable), in a lump sum in cash within 30 days after the Date of Termination, the Accrued
Obligations and (ii) timely pay or provide to the Executive the Other Benefits.

          (c) Termination for Cause. If the Company terminates the Executive’s employment with
the Company for Cause within 18 months following the Change in Control Date, then the Company shall
(i) pay the Executive, in a lump sum in cash within 30 days after the Date of Termination, the sum
of (A) the Executive’s annual base salary through the Date of Termination and (B) the amount of any
compensation previously deferred by the Executive, in each case to the extent not previously paid,
and (ii) timely pay or provide to the Executive the Other Benefits.

     4.3 Taxes.

          (a) In the event that the Company undergoes a “Change in Ownership or Control” (as defined
below), and thereafter, the Executive becomes eligible to receive “Contingent Compensation
Payments” (as defined below) the Company shall, as soon as administratively feasible after the
Executive becomes so eligible determine and notify the Executive (with reasonable detail regarding
the basis for its determinations) (i) which of the payments or benefits due to the Executive
following such Change in Ownership or Control constitute Contingent Compensation Payments, (ii) the
amount, if any, of the excise tax (the “Excise Tax”) payable pursuant to Section 4999 of the
Internal Revenue Code of 1986, as amended (the “Code”), by the Executive with respect to such
Contingent Compensation Payment and (iii) the amount of the “Gross-Up Payment” (as defined below)
due to the Executive with respect to such Contingent Compensation Payment. Within 30 days after
delivery of such notice to the Executive, the Executive shall deliver a response to the Company
(the “Executive Response”) stating either (A) that he agrees with the Company’s determination
pursuant to the preceding sentence or (B) that he disagrees with such determination, in which case
he shall indicate which payment and/or benefits should be characterized as a Contingent
Compensation Payment, the amount of the Excise Tax with respect to such Contingent Compensation
Payment and the amount of the Gross-Up Payment due to the Executive with respect to such Contingent
Compensation Payment. If the Executive states in the Executive Response that he agrees with the
Company’s determination, the Company shall make the Gross-Up Payment to the Executive within three
business days following delivery to the Company of the Executive Response. If the

7

 

Executive states in the Executive Response that he disagrees with the Company’s determination,
then, for a period of 15 days following delivery of the Executive Response, the Executive and the
Company shall use good faith efforts to resolve such dispute. If such dispute is not resolved
within such 15-day period, such dispute shall be settled exclusively by arbitration in Boston,
Massachusetts, in accordance with the rules of the American Arbitration Association then in effect.
Judgment may be entered on the arbitrator’s award in any court having jurisdiction. The Company
shall, within three business days following delivery to the Company of the Executive Response, make
to the Executive those Gross-Up Payments as to which there is no dispute between the Company and
the Executive regarding whether they should be made. The balance of the Gross-Up Payments shall be
made within three business days following the resolution of such dispute. The amount of any
payments to be made to the Executive following the resolution of such dispute shall be increased by
the amount of the accrued interest thereon computed at the prime rate announced from time to time
by The Wall Street Journal compounded monthly from the date that such payments originally were due.
In the event that the Executive fails to deliver an Executive Response on or before the required
date, the Company’s initial determination shall be final.

          (b) For purposes of this Section 4.3, the following terms shall have the following respective
meanings:

          (i) “Change in Ownership or Control” shall mean a change in the ownership or effective
control of the Company or in the ownership of a substantial portion of the assets of the
Company determined in accordance with Section 280G(b)(2) of the Code.

          (ii) “Contingent Compensation Payment” shall mean any payment (or benefit) in the
nature of compensation that is made or supplied to a “disqualified individual” (as defined
in Section 280G(c) of the Code) and that is contingent (within the meaning of Section
280G(b)(2)(A)(i) of the Code) on a Change in Ownership or Control of the Company.

          (iii) “Gross-Up Payment” shall mean an amount equal to the sum of (i) the amount of the
Excise Tax payable with respect to a Contingent Compensation Payment and (ii) the amount
necessary to pay all additional taxes imposed on (or economically borne by) the Executive
(including the Excise Taxes, state and federal income taxes and all applicable withholding
taxes) attributable to the receipt of such Gross-Up Payment. For purposes of the preceding
sentence, all taxes attributable to the receipt of the Gross-Up Payment shall be computed
assuming the application of the maximum tax rates provided by law.

     4.4 Outplacement Services. In the event the Executive is terminated by the Company
(other than for Cause, Disability or Death), or the Executive terminates employment for Good
Reason, within 18 months following the Change in Control Date, the Company shall provide
outplacement services through one or more outside firms of the Executive’s choosing up to an
aggregate of $25,000, with such services to extend until the earlier of (i) 12 months following the
termination of Executive’s employment or (ii) the date the Executive secures full time employment.

8

 

     4.5 Mitigation. The Executive shall not be required to mitigate the amount of any
payment or benefits provided for in this Section 4 by seeking other employment or otherwise.
Further, except as provided in Section 4.2(a)(ii), the amount of any payment or benefits provided
for in this Section 4 shall not be reduced by any compensation earned by the Executive as a result
of employment by another employer, by retirement benefits, by offset against any amount claimed to
be owed by the Executive to the Company or otherwise.

5. Disputes.

     5.1 Settlement of Disputes; Arbitration. All claims by the Executive for benefits
under this Agreement shall be directed to and determined by the Board of Directors of the Company
and shall be in writing. Any denial by the Board of Directors of a claim for benefits under this
Agreement shall be delivered to the Executive in writing and shall set forth the specific reasons
for the denial and the specific provisions of this Agreement relied upon. The Board of Directors
shall afford a reasonable opportunity to the Executive for a review of the decision denying a
claim. Any further dispute or controversy arising under or in connection with this Agreement shall
be settled exclusively by arbitration in Boston, Massachusetts, in accordance with the rules of the
American Arbitration Association then in effect. Judgment may be entered on the arbitrator’s award
in any court having jurisdiction.

     5.2 Expenses. The Company agrees to pay as incurred, to the full extent permitted by
law, all legal, accounting and other fees and expenses which the Executive may reasonably incur as
a result of any claim or contest (regardless of the outcome thereof) by the Company, the Executive
or others regarding the validity or enforceability of, or liability under, any provision of this
Agreement or any guarantee of performance thereof (including as a result of any contest by the
Executive regarding the amount of any payment or benefits pursuant to this Agreement), plus in each
case interest on any delayed payment at the applicable Federal rate provided for in Section
7872(f)(2)(A) of the Code.

6. Successors.

     6.1 Successor to Company. The Company shall require any successor (whether direct or
indirect, by purchase, merger, consolidation or otherwise) to all or substantially all of the
business or assets of the Company expressly to assume and agree to perform this Agreement to the
same extent that the Company would be required to perform it if no such succession had taken place.
Failure of the Company to obtain an assumption of this Agreement at or prior to the effectiveness
of any succession shall be a breach of this Agreement and shall constitute Good Reason if the
Executive elects to terminate employment, except that for purposes of implementing the foregoing,
the date on which any such succession becomes effective shall be deemed the Date of Termination.
As used in this Agreement, “Company” shall mean the Company as defined above and any successor to
its business or assets as aforesaid which assumes and agrees to perform this Agreement, by
operation of law or otherwise.

     6.2 Successor to Executive. This Agreement shall inure to the benefit of and be
enforceable by the Executive’s personal or legal representatives, executors, administrators,
successors, heirs, distributees, devisees and legatees. If the Executive should die while any
amount would still be payable to the Executive or his family hereunder if the Executive had

9

 

continued to live, all such amounts, unless otherwise provided herein, shall be paid in
accordance with the terms of this Agreement to the executors, personal representatives or
administrators of the Executive’s estate.

7. Notice.

     All notices, instructions and other communications given hereunder or in connection herewith
shall be in writing. Any such notice, instruction or communication shall be sent either (i) by
registered or certified mail, return receipt requested, postage prepaid, or (ii) prepaid via a
reputable nationwide overnight courier service, in each case addressed to the Company, at 81 Wyman
Street, Waltham, Massachusetts and to the Executive at the Executive’s principal residence as
currently reflected on the Company’s records (or to such other address as either the Company or the
Executive may have furnished to the other in writing in accordance herewith). Any such notice,
instruction or communication shall be deemed to have been delivered five business days after it is
sent by registered or certified mail, return receipt requested, postage prepaid, or one business
day after it is sent via a reputable nationwide overnight courier service. Either party may give
any notice, instruction or other communication hereunder using any other means, but no such notice,
instruction or other communication shall be deemed to have been duly delivered unless and until it
actually is received by the party for whom it is intended.

8. Miscellaneous.

     8.1 Severability. The invalidity or unenforceability of any provision of this
Agreement shall not affect the validity or enforceability of any other provision of this Agreement,
which shall remain in full force and effect.

     8.2 Injunctive Relief. The Company and the Executive agree that any breach of this
Agreement by the Company is likely to cause the Executive substantial and irrevocable damage and
therefore, in the event of any such breach, in addition to such other remedies which may be
available, the Executive shall have the right to specific performance and injunctive relief.

     8.3 Governing Law. The validity, interpretation, construction and performance of this
Agreement shall be governed by the internal laws of the Commonwealth of Massachusetts, without
regard to conflicts of law principles.

     8.4 Waivers. No waiver by the Executive at any time of any breach of, or compliance
with, any provision of this Agreement to be performed by the Company shall be deemed a waiver of
that or any other provision at any subsequent time.

     8.5 Counterparts. This Agreement may be executed in counterparts, each of which shall
be deemed to be an original but both of which together shall constitute one and the same
instrument.

     8.6 Tax Withholding. Any payments provided for hereunder shall be paid net of any
applicable tax withholding required under federal, state or local law.

     8.7 Entire Agreement. This Agreement sets forth the entire agreement of the parties
hereto in respect of the subject matter contained herein and supersedes all prior agreements,

10

 

promises, covenants, arrangements, communications, representations or warranties, whether oral
or written, by any officer, employee or representative of any party hereto in respect of the
subject matter contained herein; and any prior agreement of the parties hereto in respect of the
subject matter contained herein is hereby terminated and cancelled.

     8.8 Amendments. This Agreement may be amended or modified only by a written
instrument executed by both the Company and the Executive.

[Remainder of Page Intentionally Blank]

11

 

     IN WITNESS WHEREOF, the parties hereto have executed this Agreement as of the day and year
first set forth above.

	 	 	 	 	 
	 	THERMO ELECTRON CORPORATION

 	 
	 	By:  	/s/ Stephen G. Sheehan                                  
 	 
	 	 	Stephen G. Sheehan 	 
	 	 	Senior Vice President, Human Resources 	 
	 

	 	 	 	 	 
	 	EXECUTIVE

 	 
	 	/s/ Marijn E. Dekkers
 	 
	 	Marijn E. Dekkers 	 
	 	 	 
	 

12exv10w2

 

EXHIBIT 10.2

[THERMO LETTERHEAD]

April 7, 2008

Marijn E. Dekkers

President and Chief Executive Officer

Thermo Fisher Scientific Inc.

81 Wyman Street

Waltham, MA 02454

Dear Marijn

Reference is hereby made to your Stock Option Agreement dated February 27, 2006, and your Stock
Option Agreement dated November 9, 2006 (collectively, the “Option Agreements”). This letter
confirms our agreement that, notwithstanding Section 4.1 of the Executive Retention Agreement dated
as of November 21, 2002 (the “Retention Agreement”) and Section 6(d) of the Amended and Restated
Employment Agreement dated as of November 21, 2002, the stock options subject to the Option
Agreements shall not automatically become exercisable and shall not automatically become vested
solely upon the occurrence of a Change in Control (as such term is defined in the Retention
Agreement). Except as provided above, the Option Agreements and the terms of the stock options
subject to the Option Agreements otherwise remain in full force and effect.

Very truly yours,

/s/
Stephen P. Kaufman

Stephen P. Kaufman

Chairman of the Compensation Committee

of the Board of Directors

AGREED AND ACCEPTED:

/s/ Marijn E. Dekkers

Marijn E. Dekkers

April 7, 2008

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00140-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00140-of-00352.parquet"}]]